StonvexLoading…
StonvexStonvexStonvexCore line items from ADMA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $510.17M | $426.45M | $258.21M | $154.08M |
Operating Income | $191.44M | $138.98M | $21.63M | $-39.37M |
Net Income | $146.93M | $197.67M | $-28.24M | $-65.90M |
EPS (Diluted) | $0.60 | $0.81 | $-0.13 | $-0.33 |
Total Assets | $624.24M | $488.68M | $329.18M | $348.46M |
Total Liabilities | $146.92M | $139.66M | $193.98M | $196.49M |
Cash & Equivalents | $87.63M | $103.15M | $51.35M | $86.52M |
Free Cash Flow OCF − CapEx | $27.82M | $110.45M | $4.03M | $-73.42M |
Shares Outstanding | 237.87M | 236.62M | 226.06M | 221.82M |